(HealthDay)—The first oral blood-thinning medication for children was approved by the U.S. Food and Drug Administration, the agency announced Monday. Pradaxa (dabigatran etexilate) oral pellets were approved to treat children ages 3 months to 12 years with venous thromboembolism (VTE) directly after treatment with an injectable blood thinner for at least five days. The tablets were also...
